Diploid Genomics

Diploid Genomics, Inc. (DGI) develops integrated, multimodal precision health records by uniting phased diploid genome sequencing, advanced imaging, and clinical data. The company targets healthcare systems, biopharma, and diagnostics companies, providing a research engine that uses AI to create validated diagnostics and biomarkers. Its key differentiator is the use of telomere-to-telomere phased diploid genome sequencing to capture heritable variation often missed by conventional approaches.